The Oncology Institute, Inc. (TOI) Reports Q1 Loss of $0.21, provides guidance

Go back to The Oncology Institute, Inc. (TOI) Reports Q1 Loss of $0.21, provides guidance
TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) Delayed: 4.95 -0.06 (1.2%)
Previous Close $5.01    52 Week High $7.47 
Open $4.90    52 Week Low $7.47 
Day High $5.19    P/E N/A 
Day Low $4.90    EPS $0.00 
Volume 455,810